TP53 and pulmonary fibrosis: Fibrotic lesions in both IPF lung and experimental pulmonary fibrosis in aged mice highly express mouse double minute 4 homolog (MDM4), a matrix stiffness-regulated endogenous inhibitor of p53 [12].